Regulation of TLR4 signaling through the TRAF6/sNASP axis by reversible phosphorylation mediated by CK2 and PP4

Feng-Ming Yang1, Hui-Ming Chang2,3,4, Edward T H Yeh5,4

  • 1School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan 110301.

Insights

Protein phosphatase 4 (PP4) acts as a negative regulator in innate immunity. It dephosphorylates somatic nuclear autoantigenic sperm protein (sNASP), thereby inhibiting Toll-like receptor 4 (TLR4)-induced signaling and enhancing sepsis survival.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Toll-like receptors (TLRs) activate innate immunity via complex signaling pathways involving kinases and phosphatases.
  • Somatic nuclear autoantigenic sperm protein (sNASP) binds TNF receptor-associated factor 6 (TRAF6) in resting cells.
  • Upon TLR4 activation, a signaling complex including TRAF6, sNASP, IL-1 receptor-associated kinase 4, and casein kinase 2 (CK2) is formed, with CK2 phosphorylating sNASP.

Purpose of the Study:

  • To identify the specific phosphatase that dephosphorylates sNASP.
  • To elucidate the role of this phosphatase in regulating TLR4-induced innate immune signaling.
  • To investigate the therapeutic potential of modulating this phosphatase activity in infection models.

Main Methods:

  • Biochemical assays to identify sNASP phosphatase activity.
  • Cell-based experiments using ectopic expression and gene silencing of protein phosphatase 4 (PP4).
  • In vivo studies using mouse models of bacterial infection and sepsis, employing recombinant adenovirus for gene delivery.

Main Results:

  • Protein phosphatase 4 (PP4) was identified as the specific phosphatase for sNASP.
  • PP4 dephosphorylates phospho-sNASP (p-sNASP), terminating TRAF6 activation and downstream signaling.
  • Ectopic PP4 expression inhibited pro-inflammatory cytokine production (IL-6, TNF-α) and improved survival in a sepsis model, while PP4 silencing had opposite effects.

Conclusions:

  • PP4 acts as a negative regulator of TLR4-induced innate immunity by modulating the sNASP-TRAF6 interaction.
  • Targeting PP4 offers a potential therapeutic strategy to enhance innate immune responses and combat bacterial infections.
  • The sNASP-TRAF6-PP4 axis represents a novel regulatory mechanism in innate immune signaling.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
13.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.4K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.0K